跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,022 条关于
“hereditary amyloidosis”
全部
2,022
临床试验
1,476
药物
41
机构
4
资讯
501
去年
EU Approves WAINZUA (Eplontersen) for Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
去年
Swissmedic Authorizes Tegsedi for Hereditary Transthyretin Amyloidosis
去年
Eplontersen (Wainzua) Recommended in England and Wales for Hereditary Transthyretin Amyloidosis
去年
FDA Clears AI-Powered Ultrasound Software EchoGo® Amyloidosis for Enhanced Cardiac Amyloidosis Detection
去年
Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection
去年
Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection
去年
CRISPR Gene Editing Advances from Laboratory to Clinic with 250+ Active Trials Across Multiple Therapeutic Areas
2年前
Intellia Therapeutics Reports First Quarter 2024 Financial Results and Operational Progress
去年
Intellia's CRISPR Therapy Nex-z Shows Promise in ATTR Amyloidosis Phase 1 Trial
去年
FDA Accepts Alnylam's Vutrisiran sNDA for ATTR Amyloidosis with Cardiomyopathy
第 1 页,共 51 页
上一页
下一页